PAVmed Inc. (PAVM) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for PAVmed Inc. (PAVM:NASDAQ), powered by AI.

Current Price
$4.99
P/E Ratio
8.3
Market Cap
3M
Sector
Healthcare
What is the PAVmed Inc. stock price forecast?

PAVmed Inc. is currently trading at $4.99. View real-time AI analysis on Alpha Lenz.

What is PAVmed Inc. insider trading activity?

View the latest insider trading data for PAVmed Inc. on Alpha Lenz.

What is PAVmed Inc.'s P/E ratio?

PAVmed Inc.'s P/E ratio is 8.3.

PAVmed Inc.

NASDAQ · PAVM
$4.99+0.16(+3.21%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about PAVmed Inc.'s future dividend policy...
Alpha Chat Insight

PAVmed Inc. trades at a P/E of 8.3 (undervalued) with modest ROE of 2.5%.

Ask for details

Company Overview

PAVmed Inc. is a medical device company focused on developing innovative technologies to address unmet medical needs. The company aims to enhance patient care through minimally invasive medical solutions across various domains. PAVmed operates in sectors such as diagnostics, medical devices, and healthcare technologies. It manages a diverse portfolio of products and subsidiaries, including Lucid Diagnostics, which specializes in diagnostic tools for esophageal health, and Solys, aimed at delivering advanced biomaterial solutions. The company leverages a unique approach by quickly advancing products from concept to commercialization, striving to bring practical and efficient innovations to the healthcare industry. Headquartered in New York, PAVmed is positioned to impact the medical device market significantly by targeting high-growth healthcare segments and addressing crucial patient needs through technology advancements.

CEODr. Lishan Aklog M.D.
SectorHealthcare
IndustryMedical Devices
Employees39

Company Statistics

FY 2025

Profile

$3.34MMarket Cap
$71.00KRevenue
0.00Shares Out
39Employees

Margins

-207.04%Gross
-3218.31%EBITDA
-30126.76%Operating
-3477.46%Pre-Tax
-3477.46%Net

Valuation

8.33P/E
0.10P/B
47.07EV/Sales
-1.53EV/EBITDA
-0.64P/FCF

Growth (CAGR)

-42.68%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-7.11%ROA
2.55%ROE
-7.05%ROIC

Financial Health

$1.54MCash & Cash Equivalents
$14.97MNet Debt
74.04%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

PAVmed Inc. (ticker: PAVM) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 39 employees. Market cap is $3M.

The current price is $4.985 with a P/E ratio of 8.33x and P/B of 0.1x.

ROE is 2.55% and operating margin is -30126.76%. Annual revenue is $71,000.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
PAVmed Inc. (PAVM) Stock Forecast 2026 $4.99 — Price, Financials & Analyst Targets | Alpha Lenz